The Endocrine Society and Keystone Symposia are partnering to hold a series of joint translation scientific meetings that connect foundational (or basic) science with clinical practice across oncology, cardiometabolism, and diabetes with the aim of supporting a full bench-to-bedside and back research cycle. Keystone Symposia contributes deep connections to basic scientists and a robust infrastructure for large-scale scientific meetings, while the Endocrine Society brings clinical expertise and its scholarly journals with plans to publish conference proceedings or abstracts to attract scientists who currently lack such outlets through Keystone Symposia.
“At the heart of [this partnership] is trying to facilitate areas of discovery because there are so many meetings out there for basic scientists, but some of them may have deviated from the core intent, which is really to advance science and facilitate those types of breakthroughs,” says Chris Urena, MBA, FASAE, CAE, the Endocrine Society’s chief learning officer. The conferences are designed to inspire discovery and collaboration among basic and translational researchers, with the goal of catalyzing advances in foundational science.
Endocrine News published a clinical update in Research Highlights on 09 Jun 2026.
The item focuses on Endocrine Society and Keystone Symposia Announce Series of Joint Meetings.
Review the original article for the full source wording and details.